These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 29226017)

  • 1. Buprenorphine for Medication-Assisted Treatment of Opioid Use Disorder in Pregnancy: Relationship to Neonatal Opioid Withdrawal Syndrome.
    Chavan NR; Ashford KB; Wiggins AT; Lofwall MR; Critchfield AS
    AJP Rep; 2017 Oct; 7(4):e215-e222. PubMed ID: 29226017
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparison of neonatal outcomes in pregnant women undergoing medication-assisted treatment of opioid use disorder with methadone or buprenorphine/naloxone.
    Petrich M; Battin M; Walker E; Brown M; Abdelwahab M; Ma'ayeh M; Rood KM
    J Matern Fetal Neonatal Med; 2022 Dec; 35(26):10481-10486. PubMed ID: 36202398
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Care-by-parent model as a tool for reduction of neonatal opioid withdrawal syndrome in neonates exposed to buprenorphine maintenance therapy in-utero.
    Lawlor ML; Shook LA; McQuerry K; Srinivasan A; Johnson QB; Chavan NR; Critchfield AS
    J Matern Fetal Neonatal Med; 2020 Aug; 33(16):2718-2722. PubMed ID: 30563376
    [No Abstract]   [Full Text] [Related]  

  • 4. Can umbilical cord testing add to maternal urine drug screen for evaluation of infants at risk of neonatal opioid withdrawal syndrome?
    Gersch H; Shah D; Chroust A; Bailey B
    J Matern Fetal Neonatal Med; 2023 Dec; 36(1):2211706. PubMed ID: 37183045
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessing Neonatal Opioid Withdrawal Syndrome Severity as a Function of Maternal Buprenorphine Dose and Umbilical Cord Tissue Concentrations.
    Rana D; McLeod AR; Gaston PK; Hill DM; Pourcyrous M
    Ann Pharmacother; 2023 Aug; 57(8):892-898. PubMed ID: 36321504
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Placental aromatase expression decreased in severe neonatal opioid withdrawal syndrome.
    Townsel C; Covault JM; Hussain N; Oncken C; Nold C; Campbell WA
    J Matern Fetal Neonatal Med; 2021 Mar; 34(5):670-676. PubMed ID: 31092079
    [No Abstract]   [Full Text] [Related]  

  • 7. Prenatal Buprenorphine/Naloxone or Methadone Use on Neonatal Outcomes in Michigan.
    Goshgarian G; Jawad R; O'Brien L; Muterspaugh R; Zikos D; Ezhuthachan S; Newman C; Hsu CD; Bailey B; Ragina N
    Cureus; 2022 Aug; 14(8):e27790. PubMed ID: 36106254
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between Individual versus Community-level Social Vulnerability and Neonatal Opioid Withdrawal Syndrome among Pregnant Individuals Receiving Buprenorphine for Opioid Use Disorder.
    Mason I; Abdelwahab M; Stiles A; Wu J; Venkatesh KK; Rood KM
    Am J Perinatol; 2024 May; 41(S 01):e3157-e3163. PubMed ID: 37890511
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Medication-assisted treatment vs. detoxification for women who misuse opioids in pregnancy: Associations with dropout, relapse, neonatal opioid withdrawal syndrome (NOWS), and childhood sexual abuse.
    Macfie J; Towers CV; Fortner KB; Stuart GL; Zvara BJ; Kurdziel-Adams G; Kors SB; Noose SK; Gorrondona AM; Cohen CT
    Addict Behav Rep; 2020 Dec; 12():100315. PubMed ID: 33364323
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between prenatal opioid exposure, neonatal opioid withdrawal syndrome, and neurodevelopmental and behavioral outcomes at 5-8 months of age.
    Bakhireva LN; Holbrook BD; Shrestha S; Leyva Y; Ashley M; Cano S; Lowe J; Stephen JM; Leeman L
    Early Hum Dev; 2019 Jan; 128():69-76. PubMed ID: 30554024
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Maternal opioid use disorder and infant mortality in Wisconsin, United States, 2010-2018.
    Mallinson DC; Kuo HD; Kirby RS; Wang Y; Berger LM; Ehrenthal DB
    Prev Med; 2024 Apr; 181():107914. PubMed ID: 38408650
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Newborn Cry Acoustics in the Assessment of Neonatal Opioid Withdrawal Syndrome Using Machine Learning.
    Manigault AW; Sheinkopf SJ; Silverman HF; Lester BM
    JAMA Netw Open; 2022 Oct; 5(10):e2238783. PubMed ID: 36301544
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Maternal opioid use during pregnancy and the risk of neonatal opioid withdrawal syndrome in the offspring.
    Kristensen AW; Vestermark V; Kjærbye-Thygesen A; Eckhardt MC; Kesmodel US
    Acta Obstet Gynecol Scand; 2024 Aug; 103(8):1522-1529. PubMed ID: 38700023
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gestational buprenorphine exposure: Effects on pregnancy, development, neonatal opioid withdrawal syndrome, and behavior in a translational rodent model.
    Wallin CM; Bowen SE; Roberge CL; Richardson LM; Brummelte S
    Drug Alcohol Depend; 2019 Dec; 205():107625. PubMed ID: 31706250
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Delivery dose of methadone, but not buprenorphine, is associated with the risk and severity of neonatal opiate withdrawal syndrome.
    Lappen JR; Stark S; Bailit JL; Gibson KS
    Am J Obstet Gynecol MFM; 2020 Feb; 2(1):100075. PubMed ID: 33345989
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In Utero Exposure to Norbuprenorphine, a Major Metabolite of Buprenorphine, Induces Fetal Opioid Dependence and Leads to Neonatal Opioid Withdrawal Syndrome.
    Griffin BA; Caperton CO; Russell LN; Cabanlong CV; Wilson CD; Urquhart KR; Martins BS; Zita MD; Patton AL; Alund AW; Owens SM; Fantegrossi WE; Moran JH; Brents LK
    J Pharmacol Exp Ther; 2019 Jul; 370(1):9-17. PubMed ID: 31028107
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk factors for preterm birth among gravid individuals receiving buprenorphine for opioid use disorder.
    Abdelwahab M; Petrich M; Wang H; Walker E; Cleary EM; Rood KM
    Am J Obstet Gynecol MFM; 2022 May; 4(3):100582. PubMed ID: 35123110
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Weaning buprenorphine in pregnant patients
    Patel N; O'Brien J; Cockerham C; Hawk G; Parilla B
    J Matern Fetal Neonatal Med; 2024 Dec; 37(1):2337711. PubMed ID: 38616176
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction between buprenorphine and norbuprenorphine in neonatal opioid withdrawal syndrome.
    Tobacyk J; Parks BJ; Salazar P; Coward LU; Berquist MD; Gorman GS; Brents LK
    Drug Alcohol Depend; 2023 Aug; 249():110832. PubMed ID: 37385117
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Opioid use disorder in pregnancy.
    Harter K
    Ment Health Clin; 2019 Nov; 9(6):359-372. PubMed ID: 31857932
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.